Editorial: anti-TNF agents against vedolizumab as a second-line treatment? Not surprising tie game-authors' reply.
Sara KarlqvistMichael C SachsCarl ErikssonOla OlénScott MontgomeryJonas HalfvarsonPublished in: Alimentary pharmacology & therapeutics (2021)
Keyphrases